Llwytho...
Targeting nectin-4 by antibody-drug conjugates for the treatment of urothelial carcinoma
INTRODUCTION: Nectin-4 is a tumor-associated antigen overexpressed in urothelial carcinoma and several other malignancies. It has emerged as a compelling target for novel tumor-directed therapies, particularly as a component of antibody-drug conjugates (ADCs), a growing class of anti-cancer therapeu...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Expert Opin Biol Ther |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8224177/ https://ncbi.nlm.nih.gov/pubmed/34030536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2021.1929168 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|